Ignite Creation Date:
2025-12-25 @ 2:13 AM
Ignite Modification Date:
2026-03-21 @ 7:59 PM
Study NCT ID:
NCT00278460
Status:
COMPLETED
Last Update Posted:
2017-01-19
First Post:
2006-01-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Gemcitabine and Docetaxel in Treating Patients With Recurrent Stage III or Stage IV Non-Small Cell Lung Cancer
Sponsor:
Organization: